ENTPD1/CD39 is a promising therapeutic target in oncology

Jérémy Bastid(OREGA Biotech (France)), A Cottalorda-Regairaz(OREGA Biotech (France)), Gilles Alberici(OREGA Biotech (France)), Nathalie Bonnefoy(Université Claude Bernard Lyon 1), J-F Eliaou(Université Claude Bernard Lyon 1), Armand Bensussan(Inserm)
Oncogene
July 2, 2012
10.1038/onc.2012.269
Cited by 200Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis